NeoGenomics, Inc. Stock Issued During Period, Shares, Employee Stock Purchase Plans
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- NeoGenomics, Inc. stock issued during period, shares, employee stock purchase plans for the quarter ending 2018-03-31 was 36.92K shares, a 51.55% increase year-over-year.
- NeoGenomics, Inc. stock issued during period, shares, employee stock purchase plans for the quarter ending 2017-12-31 was 33.84K shares, a 46.83% increase year-over-year.
- NeoGenomics, Inc. stock issued during period, shares, employee stock purchase plans for the quarter ending 2017-09-30 was 23.66K shares, a 9.31% decline year-over-year.
- NeoGenomics, Inc. stock issued during period, shares, employee stock purchase plans for the quarter ending 2017-03-31 was 24.36K shares.
- NeoGenomics, Inc. stock issued during period, shares, employee stock purchase plans for fiscal 2025 was 538.43K shares, a 72.33% increase from fiscal 2024.
- NeoGenomics, Inc. stock issued during period, shares, employee stock purchase plans for fiscal 2024 was 312.44K shares, a 4.36% decline from fiscal 2023.
- NeoGenomics, Inc. stock issued during period, shares, employee stock purchase plans for fiscal 2023 was 326.70K shares, a 21.36% decline from fiscal 2022.
- NeoGenomics, Inc. stock issued during period, shares, employee stock purchase plans for fiscal 2022 was 415.45K shares, a 270.63% increase from fiscal 2021.
| Period end | Stock Issued During Period, Shares, Employee Stock Purchase Plans 3 month | Stock Issued During Period, Shares, Employee Stock Purchase Plans 12 month |
|---|---|---|
| 2025-12-31 | 538.43K shares 10-K · filed 2026-02-17 | |
| 2024-12-31 | 312.44K shares 10-K · filed 2026-02-17 | |
| 2023-12-31 | 326.70K shares 10-K · filed 2026-02-17 | |
| 2022-12-31 | 415.45K shares 10-K · filed 2025-02-18 | |
| 2021-12-31 | 112.09K shares 10-K · filed 2024-02-20 | |
| 2020-12-31 | 138.31K shares 10-K · filed 2023-02-24 | |
| 2019-12-31 | 141.91K shares 10-K · filed 2022-02-25 | |
| 2018-12-31 | 113.50K shares 10-K · filed 2021-02-25 | |
| 2018-03-31 | 36.92K shares 10-Q · filed 2018-05-08 | |
| 2017-12-31 | 33.84K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | 108.60K shares 10-K · filed 2020-02-28 |
| 2017-09-30 | 23.66K shares 10-Q · filed 2017-11-13 | |
| 2017-03-31 | 24.36K shares 10-Q · filed 2018-05-08 | |
| 2016-12-31 | 23.05K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | 98.67K shares 10-K · filed 2019-02-26 |
| 2016-09-30 | 26.09K shares 10-Q · filed 2017-11-13 | |
| 2015-12-31 | 73.96K shares 10-K · filed 2018-03-13 | |
| 2014-12-31 | 90.28K shares 10-K · filed 2017-03-14 | |
| 2013-12-31 | 76.59K shares 10-K · filed 2016-04-18 | |
| 2012-12-31 | 56.80K shares 10-K · filed 2015-03-03 | |
| 2011-12-31 | 122.40K shares 10-K · filed 2014-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |